- Home
- PPBT vs AMZE Comparison
PPBT vs AMZE Comparison
Compare PPBT & AMZE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PPBT
- AMZE
- Stock Information
- Founded
- PPBT 2010
- AMZE 2019
- Country
- PPBT Israel
- AMZE United States
- Employees
- PPBT N/A
- AMZE N/A
- Industry
- PPBT Biotechnology: Pharmaceutical Preparations
- AMZE Beverages (Production/Distribution)
- Sector
- PPBT Health Care
- AMZE Consumer Staples
- Exchange
- PPBT Nasdaq
- AMZE Nasdaq
- Market Cap
- PPBT 6.3M
- AMZE 6.6M
- IPO Year
- PPBT N/A
- AMZE 2021
- Fundamental
- Price
- PPBT $2.62
- AMZE $0.30
- Analyst Decision
- PPBT Strong Buy
- AMZE
- Analyst Count
- PPBT 1
- AMZE 0
- Target Price
- PPBT $33.00
- AMZE N/A
- AVG Volume (30 Days)
- PPBT 30.8K
- AMZE 127.5K
- Earning Date
- PPBT 05-21-2025
- AMZE 05-20-2025
- Dividend Yield
- PPBT N/A
- AMZE N/A
- EPS Growth
- PPBT N/A
- AMZE N/A
- EPS
- PPBT N/A
- AMZE N/A
- Revenue
- PPBT N/A
- AMZE $254,711.00
- Revenue This Year
- PPBT N/A
- AMZE N/A
- Revenue Next Year
- PPBT N/A
- AMZE N/A
- P/E Ratio
- PPBT N/A
- AMZE N/A
- Revenue Growth
- PPBT N/A
- AMZE N/A
- 52 Week Low
- PPBT $2.00
- AMZE $0.25
- 52 Week High
- PPBT $13.95
- AMZE $1.25
- Technical
- Relative Strength Index (RSI)
- PPBT 56.64
- AMZE N/A
- Support Level
- PPBT $2.46
- AMZE N/A
- Resistance Level
- PPBT $2.80
- AMZE N/A
- Average True Range (ATR)
- PPBT 0.20
- AMZE 0.00
- MACD
- PPBT 0.04
- AMZE 0.00
- Stochastic Oscillator
- PPBT 66.96
- AMZE 0.00
About PPBT Purple Biotech Ltd.
Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219: A dual inhibitor, small molecule that simultaneously targets Insulin Receptor Substrate 1 and 2 (IRS1/2) and Signal Transducer and Activator of Transcription (STAT3), two survival signal transduction pathways driving the development of cancer drug resistance. and CM24: is a humanized monoclonal antibody designed to block the interactions of Carcinoembryonic Antigen Related Cell Adhesion Molecule 1 (CEACAM1), a glycoprotein that plays a key role in immune regulation, cell adhesion, and tumor progression, CAPTN3.
About AMZE Amaze Holdings Inc. Common Stock
Amaze Holdings Inc is engaged in producer of low carb, low calorie, premium wines in the United States. The company offers bold, crisp, and creamy wines that embody health, warmth, and a deeper connection to wellness and an active lifestyle. The company currently sell seven proprietary varietals: Cabernet Sauvignon, Pinot Noir, Chardonnay, Sauvignon Blanc, Rose, Sparkling Rose, and a limited Reserve Napa Cabernet Sauvignon.